ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 138 filers reported holding ACCELERON PHARMA INC in Q2 2016. The put-call ratio across all filers is 6.11 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2021 | $1,188,000 | +36.6% | 6,911 | -0.3% | 0.00% | 0.0% |
Q2 2021 | $870,000 | -14.7% | 6,934 | -7.8% | 0.00% | 0.0% |
Q1 2021 | $1,020,000 | +4.2% | 7,521 | -1.6% | 0.00% | 0.0% |
Q4 2020 | $979,000 | +11.0% | 7,644 | -2.5% | 0.00% | 0.0% |
Q3 2020 | $882,000 | +42.7% | 7,840 | +20.9% | 0.00% | 0.0% |
Q2 2020 | $618,000 | +12.2% | 6,486 | +5.8% | 0.00% | 0.0% |
Q1 2020 | $551,000 | +20.3% | 6,131 | -28.9% | 0.00% | – |
Q4 2019 | $458,000 | +46.3% | 8,618 | +9.3% | 0.00% | – |
Q3 2019 | $313,000 | -0.3% | 7,886 | +3.1% | 0.00% | – |
Q2 2019 | $314,000 | -7.4% | 7,646 | +5.0% | 0.00% | – |
Q1 2019 | $339,000 | +5.0% | 7,280 | -2.2% | 0.00% | – |
Q4 2018 | $323,000 | -5.8% | 7,440 | +24.4% | 0.00% | – |
Q3 2018 | $343,000 | +61.0% | 5,980 | +36.4% | 0.00% | – |
Q2 2018 | $213,000 | -95.8% | 4,384 | -96.7% | 0.00% | -100.0% |
Q1 2018 | $5,127,000 | +1373.3% | 131,119 | +1496.7% | 0.01% | – |
Q4 2017 | $348,000 | +15.2% | 8,212 | +1.6% | 0.00% | – |
Q3 2017 | $302,000 | +17.1% | 8,080 | -4.5% | 0.00% | – |
Q2 2017 | $258,000 | +81.7% | 8,460 | +57.8% | 0.00% | – |
Q1 2017 | $142,000 | -2.7% | 5,360 | -6.9% | 0.00% | – |
Q4 2016 | $146,000 | -19.8% | 5,760 | +14.7% | 0.00% | – |
Q3 2016 | $182,000 | +5.8% | 5,020 | -0.7% | 0.00% | – |
Q2 2016 | $172,000 | +5633.3% | 5,055 | +4112.5% | 0.00% | – |
Q1 2016 | $3,000 | -50.0% | 120 | +3.4% | 0.00% | – |
Q4 2015 | $6,000 | +100.0% | 116 | 0.0% | 0.00% | – |
Q3 2015 | $3,000 | -25.0% | 116 | +3.6% | 0.00% | – |
Q2 2015 | $4,000 | +100.0% | 112 | +83.6% | 0.00% | – |
Q1 2015 | $2,000 | – | 61 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |